Mai Capital Management Oncolytics Biotech Inc Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Mai Capital Management holds 526 shares of ONCY stock, worth $405. This represents 0.0% of its overall portfolio holdings.
Number of Shares
526Holding current value
$405% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ONCY
# of Institutions
46Shares Held
1.38MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$154,3080.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$146,2540.05% of portfolio
-
Goldman Sachs Group Inc New York, NY101KShares$78,0760.0% of portfolio
-
Virtu Financial LLC New York, NY98.5KShares$75,8080.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$51,5430.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $44.6M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...